Search results
Summer COVID bump intensifies in L.A. and California, fueled by FLiRT variants
LA Times via AOL· 7 hours agoThe new COVID FLiRT subvariants are continuing to increase their dominance, fueling a rise in Los...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 7 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed ...
Pfizer Inc. (NYSE:PFE) Shares Sold by B. Riley Wealth Advisors Inc.
ETF DAILY NEWS· 6 days agoB. Riley Wealth Advisors Inc. decreased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 15.0% during the fourth quarter, according to its most recent 13F ...
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 6 days agoThe advisory committee is set to meet on June 27. Merck set the price of Capvaxive at $287 per...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 5 days agoIf it ever had a reputation for trustworthiness, it doesn't have it any longer. Get the latest from...
Marcum Wealth LLC Buys 3,926 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoMarcum Wealth LLC boosted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 11.8% during the first quarter, according to the company in its most recent filing ...
Quick hits: Wichita drought, library changes, Kobach lawsuit
KWCH· 6 days agoA look at some of the top stories for Tuesday, June 18, 2024.
S&P 500 Holds Gains Even as Nvidia Keeps Falling: Markets Wrap
Bloomberg via Yahoo Finance· 23 minutes ago(Bloomberg) -- Stocks rebounded from earlier losses as several other industries outside the...
Gateway - Quartz
Quartz· 7 days agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
CNBC· 7 days agoThe Food and Drug Administration on Monday approved Merck's new vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and ...